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In the mamudan head, tbe ded0pIlIeUt 0fmdii aYPertroP@ 
lsa~featarethatmmnaUypNC4!d~1~QJf~~ 
Idlure. This rulnptive process iavdves mdecdar changes ia the 
nlyacudim, h~9adiag the altered qression of several geaes 
coca&g prateim for aWraction antI relaxation. The expression 
of myosin heavy chain (MHC) and !wcomwic dpha-actla me+ 
scagcr riboaadeic acld @RNA) cbaages qualiitlvely during 
car&c bypertmphy; however, their accamalatioas are not coolc 
diaated. skeletd dpha&ill tbxaW@b accuamlate throaghout 
the vcabieles aad earlier thaa beta&iHC transcripts, which 
accumulate prbnarily around large coronary vessels. Skeletal 
dpbactin trenscripts dse *Lhyper~ulate” relative te car- 
diac a@ha-actii DIMA, wbese expre&a dees net change. 
Expre&on of MHC knRNA shows aa inverse relatioo; as 
&MEC accumubtes, &l’HC decreases in abundance. From 
nudear run=00 assays, we preseskt evideace that the accumulatEon 
ef these gene proaucrS is at least under partlal transcriptional 
control with developmental growth, suggestiq that those changes 
that occur with hypertropby and heart failure may be primarily 
transcrlptiomdly reguk&d. The expression oftbe mRNA for tbe 
calcium-adenosine tripbospbate (Ca’+-ATPaM of the sarcoplas- 
mic reticulum changes quantitatively wlth cardiac hypertrophy 
without the reexpres3ion f a different isoform. The relative 
mRNA and protein concentrations forthii proteia diminish with 
both cardiac hypertropby and htart failure, a change that may 
partially explain tbe deleyed relaxation rates seen in bypertro- 
phied and failing hearts. PreIiminary studies uggest that the 
transcriptional activity of this gene and that for phospbolamban, 
a regulatory protein for the sarcoplasmic reticulum Ca’+-ATPase, 
can be assayed using the nuclear run-on assays. T&se studies will 
enable a more complete understanding of tbe processes that lead 
to quantitative and qualitative changes in gene expression with 
hypectrophy and failure aad should in the future lead to the 
identilkation of geuetic targets for new drugs. 
(J Am Co11 Cadiol1993;22~Sqphnent A]:3OA-3A) 
Approximately 10 years ago, the tools of recombinant de- 
oxyribonucleic a id (IZNA) technology led to the develop- 
ment of a new concept o describe the syndrome of heart 
failure (that is, molecular alterations ofthe myocyte due to 
abnormal gene expressions). Most of the knowledge came 
from the analysis of experimental models of cardiac hyper- 
trophy, an approach justified by the fact that cardiac muscle 
hypertrophy usually precedes left ventricular dysfunction. It 
is now thought that he phenotype ofthe hypertrophied and 
failing myocardium differs fiwm that of control hearts, and 
that this could have both beneficial and harmful conse- 
quences on cardiac function. It is a process due to the altered 
expression ofnormal genes, which is very diierent from a 
genetic disease. 
myocyte contribute to the altered gene expression of the 
Rypertrophied or failing hc;rfi Gth the ide; that it could lead 
to the identification f genetic targets for completely new 
therapeutic agents. This report discusses everal studies 
from our laboratory that provide greater insights into the 
regulation of the expression of the genes encoding two 
proteins responsible for cardiac ontractility (myosin and 
actin) and two proteins responsible for cardiac relaxation 
(calcium-adenosine triphosphatase [Ca” -ATPase] of the 
sarcoplasmic reticulum and phospholamban). 
Contraction: Isomyosins and Isoactins 
The first demonstration f a change in protein structure 
under the effect of hemodynamic overload was that of the 
main contn tile protein, myosin. Since that ime, a growing 
number of molecular changes have been recognized in the 
hypertrophied myocyte, involving almost all subcellular 
structures (reviewed in Ref 1). Our aim over the past few 
years has been to try to understand what changes within the 
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Isomyosin and isoactin switches. In cardiac as in skeletal 
muscles, actin-activated myosin ATPase activity generates 
force and leads to contraction. Myosin is the main compo- 
nent of the thick filament of the sarcomere. It is a hexameric 
molecule that consists of two myosin heavy chains (MHC), 
two myosin alkali light chains (MLC,) and two regulatory 
light chains (ML&). The heavy chain subunits that contain 
the site for ATPase activity exist in two isoforms, alpha- 
MHC and beta-MHC, both of which are present in ventricles 
and atria (reviewed inRef 2 and 3). They are products of two 
different isogenes that are organized intandem on tine same 
chromosome, the beta-gene being located 4 kilobases up- 
stream of the alpha-gene (4). As for alpha-actin, which is the 
main component of the thin filament of the sarcomere, it can 
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also be present as two isoforms in the cardiac muscle cell, 
the skeletal isoform and the cardiac isoform (2). They are 
products of two genes located on different chromosomes, 
both in rodents and in humans. 
Work overload isaccompanied bya permanent induction 
of beta-MHC. with the extent of the isoform change depend- 
ing on the initial phenotype. It is large in rat ventricles and in 
human atria, which normally contain -90% alpha-MHC and 
it is small in human ventricles, which contain mainly beta- 
JHC. The change from alpha-MHC to beta-MHC (or isomy- 
osin Vl, the alpha-alpha homodimer, to V3, the beta-beta 
homodimer) esults in a slower ate of adenosine triphos- 
phate cycling by myosin and a lower velocity of contraction 
in the hypertrophied fiber. The result is an improved econ- 
omy of force development that is usually considered adap 
tive (Ref 5). The beta-MHC also increases with senescence 
(6,7). With aging, there may be a continuous loss of myo- 
cytes that could generate a greater workload on the remain- 
ing myocytes. This process may serve as a long-term e- 
chanical stimulus, resulting in the upregulation f beta-MHC 
gene expression. Because beta-MHZ is predomirrant in rat 
fetal ventricles, a theory was developed that reactivation f 
a fetal program occurs with hemodynamic overloading, 
whatever the cause. Pressure overload also induces changes 
in the expression of the alpha-actin soforms. The alpha- 
skeletal isoactin gene in rats is transitorily upregulated, and 
because it is also active in utero, the alpha-skeletal isoactin 
gene represents he second example of a fetal program 
reactivation byhemodynamic overload (7-9). Alpha-skeletal 
isoactin is not increased in the senescent myocardium (10) 
and thus the analogy between compensated hypertrophy and 
aging is apt for beta-MIX and less so with alpha-skeletal 
actin. In human hearts, in contrast to rodent hearts, alpha- 
skeletal actin is upregulated during development and is the 
major isoform of adult normal, hypertrophied and failing 
hearts (1 I). 
Rather strikingly, after imposition of pressure overload 
on the rat heart, the time course of upregulation f beta- 
MHC and alpha-skeletal ctin genes is not the same. 
Whereas the amount of beta-MHC messenger ribonucleic 
acid (mRNA) increases inproportion tc the extent of hyper- 
trophy and persists as long as the overload is maintained, 
alpha-skeletal actin mRNA retuns to control values (8,12). 
Morever, during the early stages of cardiac hypertrophy 
secondary topressure overload, skeletal lpha-a& mRNA 
is detected earlier than beta-MHC mRNA and skeletal 
alpha-actin mRNA is detectable throughout the entire left 
ventricle, whereas beta-MHC mRNA is observed mainly 
around large coronary arteries and in the inner half of the left 
ventricular wall (13). Using primer extension and exonucle- 
ase VII mapping assays, we (14) recently quantified the 
respective Teveis of each isomRNA encoding for alpha-actin 
and MHC. We found that whereas the mRNA encoding 
alpha- and beta-MHC accumulate in an antithetical manner, 
in the isoactin pair the skeletal alpha-actin mRNA “hyper- 
accumulates’* but the cardiac alpha-a& mRNA remains 
unchanged, suggesting that this latter isogene is not up- 
regulated (14). These data argue in favor of independent 
pathways of activation ofthe two main contractile proteins, 
suggesting that heir egulation islikely to be more complex 
than previously thought. 
Transcriptionai nd/or pust=transcriptiomd Legulatiun. 
Ekcause protein expression depends on both transcriptional 
and translational processes, differentiation between these 
events is necessary if we are to understand the regtdationd 
levels that control gene expressions. In collaboration with 
the group of V. Mahdavi, we determined the relative protein 
and mRNA levels for alpha-MHC and beta-MHC in hyper- 
trophied rat hearts econdary to aortic stenosis (12). We 
found that aortic banding results in a rapid accumulation f 
beta-MHC mRNA, followed by the appearance of compara- 
ble levels of the corresponding protein. This indicates that 
the MHC isoform transition i duced by pressure overload is 
mainly regulated by pretranslational mechanisms and there- 
fore could comprise transcriptional and posttranscriptional 
events. 
Analysis of the in vivo transcriptional activity of a single 
gene is complicated and requires the use of a nuclear run-on 
assay and a very sensitive assay system. Several criteria 
must be met before pursuing this approach. 1) To study 
intrinsic transcriptional activity, nuclei should be isolated 
directly from cardiac tissue. Plating of myocytes under 
certain conditions alters the accumulations of some mRNA 
through unknown mechanisms; therefore, to determine toa 
first approximation the activity of a nucleus in a cell, the 
nuclei should be isolated irectly from cardiac tissue without 
passing through an intermediate step. 2) The nuclei should 
be isolated intact, where chromatin is maintained in its 
native state and RNA polymerase activity is preserved. The 
latter can easily be tested by incubation ofthe nuclei n the 
presence and absence ofalpha-amanitin. 3) The preparation 
should be free of any detectable RNase or DNase activity, 
either of which can for obvious reasons alter the final results. 
4) The nuclei should maintain their capacity to transcribe in
vitro as they do in viva, that is, in a tissue-specific and DNA 
strand-specific manner. Cardiac-specific genes hould not be 
transcribed in nuc!ei isolated from liver cells, and normally 
only the sense strand of an RNA should be transcribed. The 
use of single-stranded M I3 vectors containing either sense or 
antisense inserts for the gene of interest is perhaps the best 
way of ensuring proper DNA strand transcription. Synthesis 
of an antisense might imply nonspecific transcriptional ac- 
tivity, resulting from disruption of the chromatin during the 
isolation process, perhaps from detergents or damage to the 
nuclei themselves. A second possibility could be the tran- 
scription of a highly homologous sequence oran authentic 
antisense that hybridizes to the minus strand of the gene in 
question. This must be determined. If all these criteria re 
met, the run-on assays probably represent a system that is as 
close to the intact cell as possible. 
Because of the inherent difficulties of working with car- 
diac tissue, only one study from contra! rats has been 
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reported (15) and only recently have we been able to isolate 
intact nuclei from myocytes of control and hemodynamically 
overloaded rat hearts that retain their transcriptional c pac- 
ity (16,17). At bii, important levels of alpha- and beta- 
MHC gene &tnscriptioa re detectable with the run-on 
assays, although alpha-MHC transcription is somewhat 
greater than that for beta-MHC. With postnatal develop- 
ment, this pattern becomes more pronounced, such that 
beta-MHC is transcribed only at very low levels 5 to 
10 days after biih (Boheler, unpublished observations). In 
contrast, beta-MHC mRNA, which predominates at 
birth, is slowly replaced by alpha-MHC transcripts over a 
period of several weeks. In 24day old rats, the mRNA 
accumulations for alpha- and beta-MHC as well as for 
cardii and skeletal lpha-actins correspond directly to the 
relative transcriptional activity for each respective gene (181, 
implying that a steady state situation has been attained 
where the level of RNA accumulation is maintained by a 
basal transcriptional ctivity. It is not clear, however, 
whether the low levels of sustained beta-MHC transcription 
seen between 5 and 25 days after bii involves all cardii 
myocytes or whether a subpopulation f cells maintains this 
relatively low transcriptional Level. The effects of pressure 
overload on the expression fbeta-MHC will be tested using 
these techniques todetermine whether its enhanced accu- 
mulations are due to transcriptional or posttranscriptional 
events. 
One of the other subunits of myosin, myosin light chain, 
(MLC,), has been the subject of a series of experiments to 
identify DNA sequences that regulate inducible xpression 
during pressure-overload hypertrophy. A short 250-base 
pairs fragment ofthe promoter region of the MLCr gene that 
can direct in vitro cardiac-specific expression of a reporter 
gene was recently delineated (19). In transgenic mice that 
harbor this 2%base pairs transgene, pressure overload 
signitkantly increased the activity of the reporter gene, 
showing transcriptional activation of the MLCz gene during 
hypertrophy (20). Other promising in vivo approaches to- 
ward the elucidation ofmechanisms that control contractile 
protein gene expression i response to hemodynamic over- 
load have been recently developed ( irect injection of DNA 
Otto the myocardim for example) (21). All these new technol- 
ogies provide very useful tools in identify& the precise 
s@ling pathways that lead to transcriptional activation of 
cardiac ontractile protein genes in response toan increased 
demand for contractile work placed on the myocardium. 
Relaxation: Calcium-Adenosine 
Triphosphatase of Sarcophwnic Reticulum 
and Phospholamban 
The process of myocardial relaxation is controlled by 
celhdar mechanisms that restore cytosolic alcium concen- 
trations at rest to about 10” moyliter. These mechanisms 
include calcium extrusion through the sarcolemma by 
sodium-calcium exchange and sarcolemmal calcium pumps, 
but the most important one is uptake of cytosolic alcium 
through the sarco(endo)plasmic reticulum Ca2+-ATPase. 
Rehtxation is modified in the hemodynamically overloaded 
heart and the reduced velocity of lengthening during relax- 
ation of the mechanically overloaded heart is accompanied 
by abnormal calcium handtiug and by modifications of the 
tension-independent h aproduction, which reflects the en- 
ergy cost of calcium cycling (reviewed in Ref 2,22 and 23). 
The role of the sarcoplasmic reticulum in these alterations 
has been stressed in many studies conducted on isolated 
microsomal vesicles. Areduction i  the calcium transport by 
the sarcoplasmic reticulum had been observed inexperimen- 
tal compensatory cardiac hypertrophy induced by mechani- 
cal overload, and a further decrease inits transport capacity 
was seen in failing hearts. The molecular defects involved in 
these alterations are now elucidated. The Ca2+-ATPase of 
the sarcoplasmic reticulum is a product of a multigene 
family, and in ventricular nd atrial tissue, a single isoform 
predominates, namely, the slow skeletal/cardiac form 
sarco(endo)plasmic reticulum Ca’+-ATPase 2a. With pres- 
sure overload, there is neither an induction of a new isoform 
nor an apparent activation of this gene. The result is a net 
decrease in its transcripts in rats, rabbits and himans, paral- 
leled by a decrease in its protein levels in rats and rabbits 
(24-27). The mRNA decrease occurs rela5ve to total rRNA 
content and total MHC RNA, indicating a potential imbalance 
between the contractile and relaxation properties of the heart, 
and is probably implicated in delayed rates of calcium tran- 
sients and myocarrlial relaxation (28). Thus, it appears that in 
hemodynamically overloaded hearts, contraction is regulated 
at least partially by isofotm switches and relaxation is regulated 
partiahy by quantitative modulation ofa single isoform. The 
mRN 4 expressions of phosphoh&an, one of the modulators 
of the &ivity of sarco(endo)plasmic ret ulum Ca”-ATPase 
2a, decreases in parallel to that of sarco(endo)plasmic ret u- 
lum Ca2’-ATPase, whit! lnay play a role in the differential 
sensitivity of hypertrophied and normal hearts to beta- 
adrenergic a tion (25). 
Almost nothing is known concerning the regulatory level 
or levels of the expression of the sarco(endo)plasmic retic- 
ulum Ca”-ATPase gene in the heart. Its mRNA accumu- 
lates markedly after birth and decreases significantly in
senescent hearts, conlbming the homologies between the 
fetal and the hypertrophied phenotypes and between pres- 
sure overload of the adult and the senescent myocyte (29). 
The close correlation between the concentrations of the 
mRNA and the protein that we found previously in rats 
suggests a pretranslational regulation, as in the case for 
myosins. The run-on assay that we recently described is 
sensitive nough to detect transcription of sarco(endo)plas- 
mic reticulum Ca’“-ATPase and phospholamban genes 
(Boheler KR, unpublished observations) and this approach 
should provide an additional tool to unravel the complex 
mechanisms responsible for diastolic dysfunction i hyper- 
trophy and congestive heart failure. 
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Conclusions 
In many disease states that lead to congestive h,:art 
failure, hypertrophy develops early and there is a late 
transition from hypertrophy to myocardial failure. The tech- 
niques of molecular biology and recombinant DNA have 
now provided the possibility both for exploring the molecu- 
lar basis for cardiac growth and hypertrophy in a completely 
new manner and for analyzing gene expressions in the failing 
human heart. in the near future, this may allow both a more 
comprehensive understanding of the pathways by which a 
fetal phenotype is reinduced by hemodynamic overload and 
the development of new diagnostic tools and therapeutic 
agents for congestive heart failure. 
References 
Boheler KR. Schwartz K. Gene expression in cardiac hypertrophy. 
Trends Caraiovasc Med 1992;2:176-82. 
Lompti AM. Mercadier JJ. Schwartz K. Changes in gene expression 
during cardiac growth. Intern Rev Cy~ol 1990: 124: 137-86. 
Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance: 
plasticity of the myocardium generated through protein isoform switches. 
J Clin Invest 1989% 1693-700. 
Mahdavi V. Chambers A. Nadal-Ginard B. Cardiac e and Pmyosin 
heavy chain genes are organized in tandem. Proc Nat1 Acad Sci USA 
1984;81:2626-30. 
_. Schwartz K. Boheler KR. de la Bastie D, et al. Switches in cardiac muscle 
gene expression as result of pressure and volume overload. Am J Physiol 
1992;262:R364-9. 
8. 
9. 
6. D’Neill L, Holbrock NJ. Fwoli J. Lakatta EG. Progressive changes 
from young atilt age to senescence in mRNA for rat cardiac myosin 
heavy chain genes. Cardioscience 1991:2:1-5. 
7. Takahashi T. Schunkkert H, lsoyama S. et al. Age-related differences in 
the expression of pmto-oacogenes and contractile protein genes in 
responie to pressure overload in Ihe rat myocardium. J Clin Invest 
1992;89:939-46. 
Schwartz K. de la Bastie D. Bouveret u. et al. u-Skeletal actin mRNAs 
accumulate in hypertrophied adult rat hearts. Circ Res 1986:59:551-5. 
Izumo S. Nadal-Ginard B. Mahdavi V. Protooncogene induction and 
repmgramming of cardiac gene expression produced by pressure over- 
load. hoc Nat1 Acad Sci USA 1988;85:339-43. 
Carrier L. Boheler KR. Chassagne C. et al. Expression of the sarcomeric 
actin isogenes in the rat heart with development and senescence. Circ Res 
1992;70:999-1005. 
Boheler KR. Carrier L. de la Bastie D. et al. Skeletal actin mRNA 
increases in the human heart during ontogenic development and is the 
major isoform of control and failing adult hearts. J Clin Invest 1991:883 
323-30. 
lzumo S. Lompn! AM, Matsuoaka R. et al. Myosin heavy chain messen- 
IO. 
Il. 
12. 
13. 
14. 
15. 
.I 
io. 
17. 
IS. 
19. 
20 
SCHWARTZ ET AL. 
GENE EXPRESSION IN THE FAILING HEART 
33A 
ger RNA and protern isoform transitions during cardiac hypertmphy. 
J Clin Irrvc~t 1987:79:970-7. 
Schiaffino S. Samuel JL. Sassoon D. et al. Uncoordinated accumulation 
of a-skeletal aclin and pmyosin heavy chain mRNAs during early stages 
of pressure overload-induced cardiac hypertrophy demonstrated by in 
situ hybridization. Circ Res l989;64:937-48. 
Chassagne C. Wisnewsky C. Schwartz K. Antithetical regulation of the 
isomyosin and isoactin mRNAs in pressure overloaded rat ventricles. 
Circ PUS 1993;72:857-64. 
McCully. Liew CC. RNA transcription in myocardii cell nuclei during 
postnatal development. B&hem J 1989:256: 1078-82. 
Chassagne C, Boheler KR. Schwartz K. Description of an in vitro 
transcription assay in nuclei isolated from contai and hemodynamically 
overloaded ral cardiac myocytes. Comptes Rendus Acad Sci [Paris] 
19991;312:7-12. 
Boheler KR. Carrier L. Chassagne C. et al. Regulation of myosin heavy 
chain and actin isogenes expression during cardiac growth. Mol Cell 
brochem 1991;104:101-7. 
Boheler KR, Chassagne C. Martin X. et al. Cardiac expressions of a- and 
pmyosin heavy chains and sarcomeric a-actins 2re~regul2ted through 
transcriotional mechanisms. J Biul Chem 1992267:12979-85. 
Henderion SA. Spencer M. Sen A. et al. Structure. organization and 
expression of the rat cardiac myosin light chain-2 gene. J Biol Chem 
1989:264:18142-8. 
Lee KJ. Ross RS, Rockman HA. et al. Myosin light chtin 2-luciferase 
transgenic mice reveal distinct regulatory pmgrams for cardiac and 
skeletal muscle specific expression of a single contractile protein gene. 
J Bioi Chem 1992~267:15875-85. 
21. Leinwand LA. Leiden JM. Gene transfer into cardiic myocytes in vivo. 
Trrqds Cardiovasc Med 1991:1:271-6. 
22. Grossman W. Diastolic dysfunction in congestive heart failure. N Engl J 
Med 1991:325: 1557-64. 
23. Hasenfuss G. Mulieri LA. Leavitt BJ. el al. Alteration of contractile 
function and excitation-contraction coupling in dilated cardiomyopathy. 
Circ Res 1992:70:1226-32. 
24. Komum 1. Kurabayashi M. Shibazaki Y. et al. Molecular cloninq and 
characterization of 2 Ca” + Mg*-dependent adenosine triphosphatase 
from rat cardiac sarcoplasmic reticulum: regulation of its expression by 
pressure overload and developmental stage. J Clin Invest 1989;83: 1102-S. 
2j. Nagai R. Zarain-Herzberg A. Brand1 CJ. et al. Regulation of myocardial 
Ca’+-ATPase and phospholamban mRNA expression in response to 
pressure overload and thyroid hormone. Proc Nat1 Acad Sci USA 
1989:86:2966-70. 
26. de la Bastie D. Levitsky D. Rappaport L, et al. Function of the 
sarcoplasmic reticulum and expression of its Ca”-ATPase gene in 
pressure overload-induced cardiac hypertmphy in the rat. Ciic Res 
1990:66:554-64. 
27. Mercadier JJ, Lompti AM, Due P. et al. Altered sarcoplasmic reticulum 
Ca:‘-ATPase gene expression in the human ventricle during end-stage 
heart failure. J Clin Invest 1990:85:305-9. 
28. Gwathmey JK. Warren SE. Briggs GM. et al. Diastolic dysfunction in 
hypertrophic cardiomyopathy. J Clin Invest 1991;87:1023-31. 
29. Lompti .4M. Lambert F. Lakatta E<r. et al. Expression of srrcoplasmic 
reticulum Ca”-ATPase and calsequectrin genes in rat heart during 
ontogenir development and aging. Circ Res 1991:69:1380-8. 
